Champions Oncology, Inc. (CSBR) stock
Close on Nov 17, 2026Market cap $63.91MP/E –Yield –
Earnings
Champions Oncology's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Champions Oncology's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q2 FY2027ended Oct 31, 2026 | Dec 14, 2026Expected | – | – | – | – | – |
| Q1 FY2027ended Jul 31, 2026 | Sep 10, 2026after the close | $15.20M | +8.6% | – | – | Release |
| Q4 FY2026ended Apr 30, 2026 | Jul 27, 2026after the close | $13.80M | +12.2% | -$0.05 | $0.01 | Release |
| Q3 FY2026ended Jan 31, 2026 | Mar 12, 2026after the close | $16.60M | -2.4% | -$0.02 | $0.04 | Release |
| Q2 FY2026ended Oct 31, 2025 | Dec 15, 2025after the close | $15.00M | +11.1% | $0.02 | $0.06 | Release |
| Q1 FY2026ended Jul 31, 2025 | Sep 15, 2025after the close | $14.00M | -0.7% | -$0.03 | $0.02 | Release |
| Q4 FY2025ended Apr 30, 2025 | Jul 23, 2025after the close | $12.30M | -12.1% | -$0.13 | -$0.07 | Release |
| Q3 FY2025ended Jan 31, 2025 | Mar 11, 2025after the close | $17.00M | +41.7% | – | – | Release |
| Q2 FY2025ended Oct 31, 2024 | Dec 11, 2024after the close | $13.50M | +16.4% | $0.05 | $0.05 | Release |
| Q1 FY2025ended Jul 31, 2024 | Sep 11, 2024after the close | $14.10M | +11.9% | $0.09 | $0.11 | Release |
| Q4 FY2024ended Apr 30, 2024 | Jul 18, 2024after the close | $14.00M | +6.9% | -$0.01 | $0.01 | Release |
| Q3 FY2024ended Jan 31, 2024 | Mar 12, 2024after the close | $12.00M | -6.3% | -$0.19 | -$0.16 | Release |
| Q2 FY2024ended Oct 31, 2023 | Dec 12, 2023after the close | $11.60M | -18.9% | -$0.15 | -$0.15 | Release |
| Q1 FY2024ended Jul 31, 2023 | Sep 13, 2023after the close | $12.60M | -8.0% | -$0.19 | -$0.16 | Release |
| Q4 FY2023ended Apr 30, 2023 | Jul 24, 2023after the close | $13.10M | +1.6% | -$0.19 | -$0.17 | Release |
| Q3 FY2023ended Jan 31, 2023 | Mar 15, 2023during market hours | $12.80M | -3.0% | – | – | Release |
| Q2 FY2023ended Oct 31, 2022 | Dec 13, 2022after the close | $14.30M | +21.2% | $0.00 | $0.01 | Release |
| Q1 FY2023ended Jul 31, 2022 | Sep 8, 2022during market hours | $13.70M | – | -$0.02 | – | Release |
| Q4 FY2022ended Apr 30, 2022 | Jul 21, 2022during market hours | $12.90M | – | -$0.03 | -$0.02 | Release |
| Q3 FY2022ended Jan 31, 2022 | Mar 15, 2022after the close | $13.20M | – | $0.05 | $0.07 | Release |
| Q2 FY2022ended Oct 31, 2021 | Dec 13, 2021during market hours | $11.80M | – | $0.02 | $0.03 | Release |
| Q1 FY2022ended Jul 31, 2021 | Sep 13, 2021after the close | – | – | – | – | Filing |
| Q4 FY2021ended Apr 30, 2021 | Jul 22, 2021before the open | – | – | – | – | Filing |
| Q3 FY2021ended Jan 31, 2021 | Mar 11, 2021after the close | – | – | – | – | Filing |
| Q2 FY2021ended Oct 31, 2020 | Dec 14, 2020after the close | – | – | – | – | Filing |
| Q1 FY2021ended Jul 31, 2020 | Sep 14, 2020after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
No open guidance: every period Champions Oncology guided for has been reported
Guidance history
Every forecast Champions Oncology put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Dec 11, 2024 | revenue growth | FY2025 | +10% – +15% | New |
| Dec 13, 2022 | growth target | FY2023 | +10% – +15% | Lowered |
| Jul 21, 2022 | top line revenue growth | FY2023 | +20% | New |
| Mar 15, 2022 | revenue growth | FY2022 | +15% – +20% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Champions Oncology filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Update
See a number that looks wrong?